HealthEquity, Inc. $HQY Stock Position Raised by Comerica Bank

Key Points

• Comerica Bank increased its stake in HealthEquity, Inc. by 43.4%, acquiring an additional 21,238 shares to bring its total holdings to 70,153 shares valued at approximately $6.2 million.
• Insider trades revealed that Director Jon Kessler sold 134,183 shares for over $15 million, marking a 34.61% decrease in his position.
• Analysts have raised their price targets for HealthEquity stock, with Barrington Research and Bank of America both increasing their target to $125.00 and maintaining a strong buy or outperform rating.

Comerica Bank lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 43.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 70,153 shares of the company's stock after buying an additional 21,238 shares during the period. Comerica Bank owned 0.08% of HealthEquity worth $6,199,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Invesco Ltd. grew its position in shares of HealthEquity by 50.6% during the 1st quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock valued at $216,171,000 after buying an additional 821,425 shares during the last quarter. Brown Advisory Inc. grew its position in shares of HealthEquity by 12.0% during the 4th quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company's stock valued at $200,154,000 after buying an additional 224,016 shares during the last quarter. Northern Trust Corp grew its position in shares of HealthEquity by 11.7% during the 4th quarter. Northern Trust Corp now owns 1,155,043 shares of the company's stock valued at $110,826,000 after buying an additional 121,001 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of HealthEquity by 1.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,100,970 shares of the company's stock valued at $97,293,000 after buying an additional 14,159 shares during the last quarter. Finally, Stephens Investment Management Group LLC grew its position in shares of HealthEquity by 1.8% during the 1st quarter. Stephens Investment Management Group LLC now owns 1,069,446 shares of the company's stock valued at $94,507,000 after buying an additional 19,009 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In related news, Director Jon Kessler sold 97,767 shares of the stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the completion of the sale, the director directly owned 75,000 shares of the company's stock, valued at $8,403,750. This represents a 56.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock valued at $32,705,007 over the last ninety days. Insiders own 1.50% of the company's stock.

Analysts Set New Price Targets

Several research analysts have commented on HQY shares. Bank of America upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Raymond James Financial restated a "strong-buy" rating and issued a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft upped their target price on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Finally, Barrington Research restated an "outperform" rating and issued a $125.00 target price on shares of HealthEquity in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $117.82.

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $1.04 during trading on Monday, reaching $89.33. The company had a trading volume of 1,519,644 shares, compared to its average volume of 946,119. The firm's fifty day moving average is $95.50 and its 200 day moving average is $95.57. The firm has a market capitalization of $7.72 billion, a PE ratio of 65.20, a price-to-earnings-growth ratio of 1.38 and a beta of 0.50. HealthEquity, Inc. has a twelve month low of $73.84 and a twelve month high of $116.65. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The company had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. During the same period in the prior year, the business posted $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.